- New ETFs
- Bond ETFs
- Currency ETFs
- Emerging Market ETFs
- Commodity ETFs
- Broad U.S. Equity ETFs
- Sector ETFs
- Specialty ETFs
Needham & Co. Upgrades Cepheid (CPHD) And Says It Will Rise 30%
Recent Articles by Benzinga Staff
- Biotech Stock Mailbag: Generex (PFE, MNKD)
- Apple Is Hoping To Have Apps For That (AAPL)
- Potential Reversals 3/19/10
- Coal Prices Ready To Burn Hot In 2010?
- Stifel Nicolaus Still Gives TriQuint A Buy (TQNT)
Upgrades
- Standpoint Research Initiates Coverage On Verizon & ATT With Buy Ratings (VZ, T)
- Benzinga’s Top Upgrades (TTEK, ETE, CPSI)
- Janney Montgomery Upgrades TTEK On Valuation
- Corning (GLW) Upgraded
- Standpoint Initiates GameStop With A Buy (GME)
Analyst Ratings
Posted on 10/14/09 at 7:52am by Benzinga Staff
Needham & Co. upgrades Cepheid (Nasdaq: CPHD) from Hold to Buy. Needham thinks Cepheid will rise close to 31% as it slapped a $17 price target on the stock. Cepheid closed yesterday at $13.17.
Needham upgraded CPHD after Cepheid's Q3 results beat Needham's expectations.
Bookmark/Search this post with:
Related Articles
Today's Trading Ideas
Featured Articles
Related News from the Stock Market
- Cepheid to Webcast Upcoming Financial Presentation
- CPHD Beats Q4 Expectations, Issues Inline Revenue Guidance For 2011
- Cepheid Reports Fourth Quarter and Full Year 2009 Results
- Cepheid Schedules 2009 Fourth Quarter and Full Year Financial Results Announcement and Webcast
- Cepheid Receives FDA Clearance for First Rapid and Accurate Surveillance Test for vanA -- the Resistance Gene Most Associated with Hospital-Acquired VRE Infections
There are 0 comments
Please note that comments may take up to one hour before they get published on the site. Please check back later to see your comments.
Post new comment
Receive Benzinga's Best 2010 Stock Idea!
